Health and lifestyle features.


At its meeting in Paris on 12-13 December, the UNITAID Executive Board demonstrated its continued commitment to scaling up access for HIV/AIDS and malaria by allocating an extra US$ 138 million to the two diseases.

UNITAID STATEMENT ON WORLD AIDS DAY 2011 - Keep the Momentum on Quality, Innovation and Healthy Markets

UNITAID is committed to building on 10 years of historic progress in the fight against AIDS and keep the agenda moving forward to the next level of cost-effective quality care. 

New studies confirm health benefits of red wine

Two new meta studies published in the Journal Nature, one authored by Dr. David Gems, and the second one by Drs. Auwerx and Canto, examine previous studies of red wine's ability to promote human health and longevity.  

Sweet Cures New Product Diabetrose – Utilises Fat-Burning Metabolism

Sweet Cures of York, (UK) is achieving phenomenal sales with the company's new product – 'Diabetrose™', based on arabinose, which is the natural substance in the raw food diet that helps us mammals release the glucose from the food we eat in a sustained way.

UNITAID Landmark Report on HIV Diagnostics Hails a New Decade of Innovation and Access for Developing World - Diagnostics key to the HIV/AIDS Response

In the lead-up to the United Nations High Level Meeting on AIDS, next week, UNITAID today releases a landmark report revealing that innovative technologies to test and monitor HIV/AIDS could soon be within reach of the world’s poorest regions.

ESTHERAID : le premier programme de partenariat entre ESTHER et UNITAID

ESTHER lance au Bénin son projet ESTHERAID, dont l’objectif est d’améliorer l’accès aux traitements antirétroviraux, dans 5 pays : Bénin, Burkina Faso, Cameroun, Mali et République Centrafricaine.

Shréis Scalene awarded Federal QTDP grant to advance use of the CYTOTRON

The CYTOTRON is a Rotational Field Quantum Magnetic Resonance device to treat cancer and improve drug targeting and delivery...

Forward Pharma Initiates Phase II Efficacy and Safety Trial for FP187

A randomised, double blind, placebo controlled efficacy and safety trial of different doses/dose regimens of FP187 compared to placebo in moderate to severe plaque psoriasis.

Spreading the word on flu jabs!

West country company vows to make communication easier and cheaper for UK doctors' surgeries...

Women who pluck too much turn to eyebrow transplants

Some over-tweezed. Others simply want a bushier brow. Across the country, women (and some men) are discovering a new solution to their eyebrow woes: transplants.


Subscribe to RSS - Health